REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/05/2026
Back to search
Official data from USPTO
ICE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ICE
ST13
US500000088822399Class
1, 5, 42, 44
Filing
88822399
Registration
6236954
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
01/06/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
03/05/2020
Registration date
01/05/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/05/2021
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Mannheim, DE
Examiner
ROSSMAN,WILLIAM M
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Affimed GmbH
Affimed GmbH
Representatives
Shauna M. Wertheim THE MARBURY LAW GROUP, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological and biochemical preparationsin particular in form of antibodiesantibody derivativesbinding proteins and peptides for scientific laboratory and experimentation purposesin particular for conducting experimental assaysother than for medical or veterinary purposes
Class 5
Pharmaceutical and veterinary preparationsbiological and biochemical preparations in form of antibodiesantibody derivativesbinding proteins and peptides for medical or veterinary diagnostic purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cellsin particular with binding affinity to T cells and natural killer (NK) cellsin particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic usein particular in form of antibodiesantibody derivativesbinding proteins and peptides; biological and biochemical preparations in form of antibodiesantibody derivativesbinding proteins and peptides for use within the framework of experimental and medical or veterinary assays
Class 42
Scientific and technological servicesresearch and design in the field of immuno-therapyin particular in the field of immuno-oncology; scientific and technological servicesresearch and design in the field of virology; scientific and technological servicesresearch and design in the field of antiinfectives; scientific and technological servicesresearch and design in the field of neurodegenerative diseases; scientific and technological servicesresearch and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodiesantibody derivativesbinding proteins and peptides; scientific and technological servicesresearch and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunityin particular in the field of immune-oncology; industrial research in the field of immuno-oncology
Class 44
Medical servicesin particular in the field of immunotherapyin particular in the field of immuno-oncology; medical services in the field of virology; medical services in the field of antiinfectives; medical services in the field of neurodegenerative diseases; medical services in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodiesantibody derivativesbinding proteins and peptides; medical services in the field of immunotherapy by means of activating or modulating innate and adaptive immunityin particular in the field of immuno-oncology
Publications
History of USPTO decisions and trademark events.
32 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/20/2020
PUBO
PUBLISHED FOR OPPOSITION
10/20/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/11/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/11/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/11/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/11/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/08/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/01/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/18/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/14/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/11/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2020
ALIE
ASSIGNED TO LIE
07/31/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/17/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/03/2020
GNRT
NON-FINAL ACTION E-MAILED
06/03/2020
CNRT
NON-FINAL ACTION WRITTEN
06/03/2020
DOCK
ASSIGNED TO EXAMINER
05/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2020
NWAP
NEW APPLICATION ENTERED
03/09/2020
Continuous trademark protection
Get notified about every new filing that threatens ICE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.